From the Daiichi Sankyo annual report:
" Phase III clinical trials were completed in Japan for the anti-influenza drug CS-8958. The Company plans to submit an application for regulatory approval during fiscal 2009."
Note they have a slightly different FY. Sounds like they are still positive on the trial.